Correlation of deregulated like-acetylglucosaminyl transferase and aberrant α-dystroglycan expression with human tongue cancer metastasis

Journal of Oral and Maxillofacial Surgery

Volumn 72, Issue 6, 2014, Pages 1106-1118

  Zhang, Han Zhong ^a   Xia, Xiao Yan ^a   Zhu, Fei ^a   Shen, Hui ^a   Song, Kai ^a   Shang, Zheng Jun ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; ALPHA DYSTROGLYCAN; GLYCOL; LAMININ; LIKE ACETYLGLUCOSAMINYL TRANSFERASE PROTEIN; N ACETYLGLUCOSAMINYLTRANSFERASE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER CELL; CELL ADHESION ASSAY; CELL INVASION ASSAY; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; DNA MODIFICATION; EPIGENETICS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; MOUTH MUCOSA; ORAL CANCER CELL LINE; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TONGUE CANCER; TONGUE CARCINOMA; WESTERN BLOTTING;

AZACITIDINE; CARCINOMA, SQUAMOUS CELL; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; DNA METHYLATION; DNA MODIFICATION METHYLASES; DYSTROGLYCANS; ENZYME INHIBITORS; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOSYLATION; HUMANS; IMMUNOHISTOCHEMISTRY; LAMININ; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; N-ACETYLGLUCOSAMINYLTRANSFERASES; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PLASMIDS; PROMOTER REGIONS, GENETIC; TONGUE NEOPLASMS; TRANSFECTION;

EID: 84901016330     PISSN: 02782391     EISSN: 15315053     Source Type: Journal    
DOI: 10.1016/j.joms.2013.12.031     Document Type: Article

References (38)

1. J.F.B. Ferlay, P. Pisani, and D. Parkin GLOBOCAN 2002. Cancer Incidence, Mortality and Prevalence Worldwide. IARC Cancer Base No 5 Version 2.0 2004 IARC Press Lyon, France
2. O.W. Petersen, L. Ronnov-Jessen, and A.R. Howlett et al. Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells Proc Natl Acad Sci U S A 89 1992 9064
3. O. Ibraghimov-Beskrovnaya, J.M. Ervasti, and C.J. Leveille et al. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix Nature 355 1992 696
4. K.H. Holt, R.H. Crosbie, and D.P. Venzke et al. Biosynthesis of dystroglycan: Processing of a precursor propeptide FEBS Lett 468 2000 79
5. S.J. Winder The complexities of dystroglycan Trends Biochem Sci 26 2001 118
6. P.A. Brennan, J. Jing, and M. Ethunandan et al. Dystroglycan complex in cancer Eur J Surg Oncol 30 2004 589
7. C. Losasso, F. Di Tommaso, and A. Sgambato et al. Anomalous dystroglycan in carcinoma cell lines FEBS Lett 484 2000 194
8. L.T. Martin, M. Glass, and E. Dosunmu et al. Altered expression of natively glycosylated alpha dystroglycan in pediatric solid tumors Hum Pathol 38 2007 1657
9. Y.W. Moon, S.Y. Rha, and X. Zhang et al. Increments of alpha-dystroglycan expression in liver metastasis correlate with poor survival in gastric cancer J Surg Oncol 100 2009 459
10. A. Sgambato, M. Migaldi, and M. Montanari et al. Dystroglycan expression is frequently reduced in human breast and colon cancers and is associated with tumor progression Am J Pathol 162 2003 849
11. A. Sgambato, A. Camerini, and D. Amoroso et al. Expression of dystroglycan correlates with tumor grade and predicts survival in renal cell carcinoma Cancer Biol Ther 6 2007 1840
12. A. Sgambato, M.A. Di Salvatore, and B. De Paola et al. Analysis of dystroglycan regulation and functions in mouse mammary epithelial cells and implications for mammary tumorigenesis J Cell Physiol 207 2006 520
13. A. Calogero, E. Pavoni, and T. Gramaglia et al. Altered expression of alpha-dystroglycan subunit in human gliomas Cancer Biol Ther 5 2006 441
14. J. Jing, C.F. Lien, and S. Sharma et al. Aberrant expression, processing and degradation of dystroglycan in squamous cell carcinomas Eur J Cancer 40 2004 2143
15. A. Sgambato, B. De Paola, and M. Migaldi et al. Dystroglycan expression is reduced during prostate tumorigenesis and is regulated by androgens in prostate cancer cells J Cell Physiol 213 2007 528
16. J. Muschler, D. Levy, and R. Boudreau et al. A role for dystroglycan in epithelial polarization: Loss of function in breast tumor cells Cancer Res 62 2002 7102
17. A. Sgambato, A. Camerini, and B. Faraglia et al. Increased expression of dystroglycan inhibits the growth and tumorigenicity of human mammary epithelial cells Cancer Biol Ther 3 2004 967
18. Z.J. Shang, M. Ethunandan, and D.C. Gorecki et al. Aberrant expression of beta-dystroglycan may be due to processing by matrix metalloproteinases-2 and -9 in oral squamous cell carcinoma Oral Oncol 44 2008 1139
19. X. Jiang, S. Rieder, and N.A. Giese et al. Reduced alpha-dystroglycan expression correlates with shortened patient survival in pancreatic cancer J Surg Res 171 2011 120
20. M. Kanagawa, F. Saito, and S. Kunz et al. Molecular recognition by LARGE is essential for expression of functional dystroglycan Cell 117 2004 953
21. R. Barresi, D.E. Michele, and M. Kanagawa et al. LARGE can functionally bypass alpha-dystroglycan glycosylation defects in distinct congenital muscular dystrophies Nat Med 10 2004 696
22. T. Ushijima, T. Nakajima, and T. Maekita DNA methylation as a marker for the past and future J Gastroenterol 41 2006 401
23. M. Weber, I. Hellmann, and M.B. Stadler et al. Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome Nat Genet 39 2007 457
24. A. Bird The essentials of DNA methylation Cell 70 1992 5
25. K.D. Tremblay, J.R. Saam, and R.S. Ingram et al. A paternal-specific methylation imprint marks the alleles of the mouse H19 gene Nat Genet 9 1995 407
26. M. Peyrard, E. Seroussi, and A.C. Sandberg-Nordqvist et al. The human LARGE gene from 22q12.3-q13.1 is a new, distinct member of the glycosyltransferase gene family Proc Natl Acad Sci U S A 96 1999 598
27. D.B. de Bernabe, K. Inamori, and T. Yoshida-Moriguchi et al. Loss of alpha-dystroglycan laminin binding in epithelium-derived cancers is caused by silencing of LARGE J Biol Chem 284 2009 11279
28. B. Li, W. Liu, and L. Wang et al. CpG island methylator phenotype associated with tumor recurrence in tumor-node-metastasis stage I hepatocellular carcinoma Ann Surg Oncol 17 2010 1917
29. D.E. Michele, R. Barresi, and M. Kanagawa et al. Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies Nature 418 2002 417
30. A. Sgambato, E. Tarquini, and F. Resci et al. Aberrant expression of alpha-dystroglycan in cervical and vulvar cancer Gynecol Oncol 103 2006 397
31. M.D. Henry, M.B. Cohen, and K.P. Campbell Reduced expression of dystroglycan in breast and prostate cancer Hum Pathol 32 2001 791
32. S.S. Cross, J. Lippitt, and A. Mitchell et al. Expression of beta-dystroglycan is reduced or absent in many human carcinomas Histopathology 53 2008 561
33. A.K. Esser, M.R. Miller, and Q. Huang et al. Loss of LARGE2 disrupts functional glycosylation of alpha-dystroglycan in prostate cancer J Biol Chem 288 2013 2132
34. M. Esteller Epigenetics in cancer N Engl J Med 358 2008 1148
35. E.G. Hayman, E. Engvall, and E. Ruoslahti Concomitant loss of cell surface fibronectin and laminin from transformed rat kidney cells J Cell Biol 88 1981 352
36. M.D. Henry, and K.P. Campbell Dystroglycan inside and out Curr Opin Cell Biol 11 1999 602
37. A. Sgambato, and A. Brancaccio The dystroglycan complex: From biology to cancer J Cell Physiol 205 2005 163
38. T. Yoneyama, K. Angata, and X. Bao et al. Fer kinase regulates cell migration through alpha-dystroglycan glycosylation Mol Biol Cell 23 2012 771